PCM
BSX icon

Prelude Capital Management’s Boston Scientific BSX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,731
Closed -$780K 1018
2025
Q1
$780K Sell
7,731
-5,060
-40% -$510K 0.06% 313
2024
Q4
$1.14M Buy
+12,791
New +$1.14M 0.07% 285
2024
Q3
Sell
-4,357
Closed -$336K 1184
2024
Q2
$336K Buy
+4,357
New +$336K 0.02% 664
2023
Q1
Sell
-20,881
Closed -$966K 1099
2022
Q4
$966K Buy
+20,881
New +$966K 0.05% 356
2021
Q3
Sell
-35,151
Closed -$1.5M 1409
2021
Q2
$1.5M Buy
+35,151
New +$1.5M 0.04% 311
2021
Q1
Sell
-24,795
Closed -$891K 1118
2020
Q4
$891K Buy
24,795
+7,489
+43% +$269K 0.02% 231
2020
Q3
$661K Sell
17,306
-41,933
-71% -$1.6M 0.03% 229
2020
Q2
$2.08M Buy
59,239
+59,174
+91,037% +$2.08M 0.11% 64
2020
Q1
$2K Sell
65
-39,240
-100% -$1.21M ﹤0.01% 860
2019
Q4
$1.78M Sell
39,305
-1,719
-4% -$77.7K 0.07% 99
2019
Q3
$1.67M Buy
41,024
+19,348
+89% +$787K 0.08% 101
2019
Q2
$932K Buy
21,676
+2,042
+10% +$87.8K 0.05% 187
2019
Q1
$754K Sell
19,634
-33,266
-63% -$1.28M 0.04% 210
2018
Q4
$1.87M Buy
52,900
+28,358
+116% +$1M 0.13% 108
2018
Q3
$945K Sell
24,542
-9,044
-27% -$348K 0.05% 244
2018
Q2
$1.1M Sell
33,586
-52,549
-61% -$1.72M 0.07% 225
2018
Q1
$2.35M Buy
86,135
+51,534
+149% +$1.41M 0.17% 84
2017
Q4
$858K Sell
34,601
-11,939
-26% -$296K 0.07% 244
2017
Q3
$1.36M Buy
+46,540
New +$1.36M 0.12% 161
2017
Q2
Hold
0
1492
2016
Q4
Sell
-45,364
Closed -$1.08M 1505
2016
Q3
$1.08M Buy
45,364
+13,732
+43% +$327K 0.11% 184
2016
Q2
$739K Sell
31,632
-6,397
-17% -$149K 0.1% 204
2016
Q1
$715K Buy
38,029
+16,501
+77% +$310K 0.1% 196
2015
Q4
$397K Buy
+21,528
New +$397K 0.06% 296
2015
Q2
Sell
-27,764
Closed -$493K 1616
2015
Q1
$493K Buy
27,764
+2,569
+10% +$45.6K 0.07% 331
2014
Q4
$334K Buy
+25,195
New +$334K 0.05% 425
2014
Q1
Sell
-7,255
Closed -$87K 1673
2013
Q4
$87K Buy
+7,255
New +$87K 0.01% 826
2013
Q3
Sell
-9,900
Closed -$92K 1583
2013
Q2
$92K Buy
+9,900
New +$92K 0.02% 593